June 3, 2025 Sophia Vida
Breaking News

BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process

Upon SEC approval of the amended Form 10, BioStem expects to advance its uplisting to Nasdaq POMPANO BEACH, Fla., June 3, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today provides … Continue reading “BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process”